NM_002906.4:c.1154A>C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002906.4(RDX):c.1154A>C(p.Glu385Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000756 in 1,614,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002906.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000171 AC: 43AN: 251462Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135914
GnomAD4 exome AF: 0.0000684 AC: 100AN: 1461870Hom.: 0 Cov.: 30 AF XY: 0.0000784 AC XY: 57AN XY: 727236
GnomAD4 genome AF: 0.000144 AC: 22AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74506
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
This variant is present in population databases (rs146713867, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with RDX-related conditions. ClinVar contains an entry for this variant (Variation ID: 229197). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 385 of the RDX protein (p.Glu385Ala). -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Glu385Ala var iant in RDX has been identified by our laboratory in one individual with hearing loss who had an alternate genetic cause of their hearing loss identified. This variant has been identified in 0.02% (52/277,224) total chromosomes across sever al populations by the Genome Aggregation Database (gnomAD, http://gnomad.broadin stitute.org; dbSNP rs146713867). Although this variant has been seen in the gene ral population, its frequency is not high enough to rule out a pathogenic role. The glutamic acid (Glu) at position 385 is not highly conserved in mammals and e volutionary distant species, and two mammals (elephant and cape golden mole) car ry an alanine (Ala) at this position, which suggests that a change at this posit ion may be tolerated. Additional computational prediction tools do not provide s trong support for or against an impact to the protein. In summary, while the cli nical significance of the p.Glu385Ala variant is uncertain, the frequency and co nservation data suggest that it is more likely to be benign. ACMG/AMP Criteria a pplied: BP4 -
Inborn genetic diseases Uncertain:1
The c.1154A>C (p.E385A) alteration is located in exon 11 (coding exon 10) of the RDX gene. This alteration results from a A to C substitution at nucleotide position 1154, causing the glutamic acid (E) at amino acid position 385 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at